[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Cheung et al., 1996 - Google Patents

Increased lipase inhibition in uremia: Identification of pre-β-HDL as a major inhibitor in normal and uremic plasma

Cheung et al., 1996

View PDF
Document ID
17123388197240943959
Author
Cheung A
Parker C
Ren K
Iverius P
Publication year
Publication venue
Kidney international

External Links

Snippet

Increased lipase inhibition in uremia: Identification of pre-β-HDL as a major inhibitor in normal and uremic plasma. The hypertriglyceridemia commonly observed in uremia has been attributed to an abnormally high inhibitor activity in plasma for lipoprotein lipase (LPL) …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Similar Documents

Publication Publication Date Title
Cheung et al. Increased lipase inhibition in uremia: Identification of pre-β-HDL as a major inhibitor in normal and uremic plasma
Horowitz et al. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein AI in subjects with low levels of high density lipoprotein cholesterol.
Karpe et al. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
Goldberg et al. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey
Stalenhoef et al. Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia
Goldberg et al. Association of plasma lipoproteins with postheparin lipase activities.
McPherson et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.
Lee et al. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency
De Sain-Van Der Velden et al. Evidence for increased synthesis of lipoprotein (a) in the nephrotic syndrome.
Muls et al. Lipoprotein distribution and composition in the human nephrotic syndrom
Alaupovic et al. Isolation and characterization of an apoA-II-containing lipoprotein (LP-A-II: B complex) from plasma very low density lipoproteins of patients with Tangier disease and type V hyperlipoproteinemia.
Cabezas et al. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides
Nakajima et al. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay
KURASAWA et al. Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperalphalipoproteinemia
McLeod et al. Plasma lipoproteins and lecithin: cholesterol acyltransferase distribution in patients on dialysis
Kashyap et al. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome
Schaefer et al. In vivo metabolism of apolipoprotein AI in a patient with homozygous familial hypercholesterolemia.
Duhamel et al. Plasma lipoprotein and apolipoprotein profile in alcoholic patients with and without liver disease: on the relative roles of alcohol and liver injury
Eisenberg et al. Enhanced metabolism of normolipidemic human plasma very low density lipoprotein in cultured cells by exogenous apolipoprotein E-3.
Marcoux et al. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins
Demant et al. Metabolism of apoB-100-containing lipoproteins in familial hyperchylomicronemia.
Wakabayashi et al. Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment
Fruchart et al. Effect of fenofibrate treatment on type III hyperlipoproteinemia
Dieplinger et al. Plasma apolipoprotein A‐IV metabolism in patients with chronic renal disease
Cho et al. The function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndrome patients